疫苗学《Vaccines》——6th Edition by (美)普洛特金

rojjer

% k1 B2 B: H" I1 X1 v+ |

Vaccines, 6th Edition

Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.

2 i/ ]8 B. U1 v5 Q* Phttp://yun.baidu.com/share/link?shareid=2079860221&uk=3810996606
4 {! R" f+ h5 f% q/ ~; X6 M
SECTION 1: General aspects of vaccination
/ f- z( A( M: x" C, ~8 {+ v1 A short history of vaccination 1
2 Vaccine immunology 14
2 Z* W3 `$ f3 d0 P$ f3 The vaccine industry 33
4 Vaccine manufacturing 44
5 Evolution of adjuvants across the centuries 58
, }7 x( J' |, t; `6 Vaccine additives and manufacturing residuals in the United States:
9 K1 n" ?: G; L) M. c; c7 l5 T7 Hlicensed vaccines 71
4 W4 _' R7 p4 @9 T7 Passive immunization 80
8 General immunization practices 88
SECTION 2: Licensed vaccines
* b* f3 @) ^6 ~& b9 g$ `4 ~% _9 Adenovirus vaccines 113
( \$ w2 n. |3 }+ u# I% T+ y7 C10 Anthrax vaccines 127
11 Cholera vaccines 141
12 Diphtheria toxoid 153
13 Haemophilus influenzae vaccines 167
14 Hepatitis A vaccines 183
! q$ L9 B" k$ o( {15 Hepatitis B vaccines 205
1 l; E- W; o+ f& O( `. Y16 Human papillomavirus vaccines 235
$ M; M, i( o" h4 b2 _17 Inactivated influenza vaccines 257
5 ]" e) a6 v* z  e  f18 Influenza vaccine-live 294
. d+ X; l# _* G( A  v( w19 Japanese encephalitis vaccines 312
: L" y; a5 C) k' \# b20 Measles vaccines 352
( L/ O, \+ _* q3 }  ]21 Meningococcal vaccines 388
: p9 ?' T+ [: {4 b" ^4 w22 Mumps vaccine 419
23 Pertussis vaccines . 447
24 Plague vaccines 493
0 {6 }( |& Z8 L) C1 o! X2 F1 ]( ?25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
26 Pneumococcal polysaccharide vaccines 542
27 Poliovirus vaccine-inactivated . 573
4 p& i+ c6 A" L! j7 w5 X28 Poliovirus vaccine-live 598
# V9 `# |; ^7 z! c29 Rabies vaccines .646
4 [# Y  O3 W9 }$ C! m* c$ y, }30 Rotavirus vaccines . 669
$ k- @+ U# H  z# f8 V31 Rubella vaccine 688
+ s) A0 r$ X% d" y0 C5 j32 Smallpox and vaccinia 718
$ U; j* C/ D( C33 Tetanus toxoid 746
5 T1 ^" e; w7 ^+ a34 Tick-borne encephalitis virus vaccines 773
35 Tuberculosis vaccines 789
36 Typhoid fever vaccines 812
+ M8 E9 A2 ]3 F2 C0 g37 Varicella vaccine 837
/ G* y( A$ h/ J38 Yellow fever vaccine 870
39 Zoster vaccine 969
# ^5 Z& G2 s! ]- r4 P/ N6 R5 h% u40 Combination vaccines 981
3 B8 f! R' @& g+ J2 \* s( H) c7 Q9 HSECTION 3: Vaccines in development and new vaccine strategies
41 Biodefense and special pathogen vaccines 1008
3 r& A; \3 M& l# ^5 T42 Therapeutic cancer vaccines 1018
1 B- B8 E- `, z+ X# A: `3 x43 Cytomegalovirus vaccines 1032
44 Dengue vaccines 1042
) Z, s* x: V& s- f$ U) w5 \6 z45 Diarrhea caused by bacteria 1052
( q3 _% W, `5 d46 Ebola vaccine 1060
8 o; H& x) J/ g& W! i* m47 Epstein-Barr virus vaccines 1068
* ?5 w+ b  q$ p; e1 q1 J2 Z48 Hepatitis C vaccines 1074
2 {+ L* r. @6 {6 y- _" r/ k49 Hepatitis E vaccines 1085
50 Herpes simplex virus vaccines 1090
51 Human immunodeficiency virus vaccines 1097
- E, c: d# f5 n: y( g52 Lyme disease vaccines 1122
9 T% A6 n) V8 h0 |+ Q9 K# z: r9 A53 Malaria vaccines 1133
54 Noninfectious disease vaccines 1138
55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
2 k& k4 v3 d8 i( U' H56 Parasitic disease vaccines 1154
57 Staphylococcus aureus vaccines 1161
58 Streptococcus group A vaccines 1169
59 Streptococcus group B vaccines 1176
. k) W) ?$ J* P7 r1 W60 Technologies for making new vaccines 1182
61 Alternative vaccine delivery methods 1200
# h; E. [4 M4 [( w! Y. K62 The development of gene-based vectors for immunization 1232
% ]& d) Z; q  n; zSECTION 4: Vaccination of special groups
8 \7 N3 f" ?! f7 t! f3 r7 q( ~63 Vaccination of immunocompromised hosts 1243
- |& v7 I0 M/ N0 F, x1 j64 Vaccination of human immunodeficiency virus-infected persons 1257
) |7 y5 m0 L5 Q% ]5 t# k- q65 Vaccines for international travel 1270
66 Vaccines for health care personnel 1290
SECTION 5: Public health and regulatory issues
3 s3 G9 Q0 {9 {67 Immunization in the United States 1310
68 Immunization in Europe . 1334
. u1 r" j# B9 h69 Immunization in the Asia-Pacific region 1353
/ a  n# G5 v7 s7 ^8 v; }. y1 i70 Immunization in developing countries 1369
71 Community immunity 1395
6 B( t- W" Q/ d* a8 V72 Economic analyses of vaccine policies 1413
  a: F* Y) G9 K' }9 m73 Regulation and testing of vaccines 1427
74 Regulation of vaccines in Europe 1447
4 U: C4 R& \2 ^3 P0 ~75 Regulation of vaccines in developing countries 1454
76 Vaccine safety 1464
) j, B9 v; f1 K77 Legal issues . 1481
78 Ethics 1508
5 E0 \2 L2 U/ E9 \* n, L
/ @' v* q( J- k' F1 i0 [3 f

) k) q) i+ [$ m% M. |% O6 K+ _* B+ N

salina

非常感谢

zhpu2008

谢谢分享

zhpu2008

怎么看不到相关下载呀

rojjer

Vaccines, 6th Edition

! `1 e+ s/ @+ P( R2 @& }Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.

http://yun.baidu.com/share/link? ... 1&uk=3810996606
1 U; n$ _! p. D" ~8 J
SECTION 1: General aspects of vaccination
( O8 R( q  r- Q0 D* B' M* v1 A short history of vaccination 1
2 Vaccine immunology 14
9 G5 n& b: \; X# u. n% c( l3 The vaccine industry 33
" {6 X  s8 T" Z% U2 x7 T4 Vaccine manufacturing 44
8 r& S4 l- P' D: K5 Evolution of adjuvants across the centuries 58
6 Vaccine additives and manufacturing residuals in the United States:
licensed vaccines 71
( X: H# z' S: F5 D9 x/ D  z/ e# Q7 Passive immunization 80
8 General immunization practices 88
4 ^( T) h* X0 N  p8 qSECTION 2: Licensed vaccines
, L+ g* l, a; `! ?0 Q9 Adenovirus vaccines 113
$ l, Z1 [  g2 w' Y( K- K10 Anthrax vaccines 127
11 Cholera vaccines 141
12 Diphtheria toxoid 153
13 Haemophilus influenzae vaccines 167
( w5 R. e  ^' G/ f14 Hepatitis A vaccines 183
1 `2 m  M2 b# c/ F' e% r15 Hepatitis B vaccines 205
3 J+ ^1 V1 u. f: D16 Human papillomavirus vaccines 235
2 d% [& Z8 ]9 r1 p: i) G17 Inactivated influenza vaccines 257
18 Influenza vaccine-live 294
9 j3 ~  X2 q) d; d5 Q$ \# o19 Japanese encephalitis vaccines 312
; d% v2 H* f# k2 m) z20 Measles vaccines 352
21 Meningococcal vaccines 388
22 Mumps vaccine 419
23 Pertussis vaccines . 447
8 `- {4 V4 m) `' X) ?1 L  ~1 p" d7 |% K24 Plague vaccines 493
9 _* x: z3 L8 W25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
  u; G3 G% g* N1 }! }26 Pneumococcal polysaccharide vaccines 542
) W9 S, i1 s/ \8 }! L27 Poliovirus vaccine-inactivated . 573
28 Poliovirus vaccine-live 598
29 Rabies vaccines .646
30 Rotavirus vaccines . 669
/ @7 I5 d8 m" ?! \( c* J3 ?31 Rubella vaccine 688
7 X( M: i* S7 _! g8 `32 Smallpox and vaccinia 718
33 Tetanus toxoid 746
34 Tick-borne encephalitis virus vaccines 773
; B/ E& t7 ^2 g: G35 Tuberculosis vaccines 789
4 n$ }' S, W# h36 Typhoid fever vaccines 812
37 Varicella vaccine 837
0 F- ^0 i% t* M( h  F+ O7 N7 u7 W; f38 Yellow fever vaccine 870
39 Zoster vaccine 969
40 Combination vaccines 981
SECTION 3: Vaccines in development and new vaccine strategies
+ U1 d6 l9 j; l' `- U41 Biodefense and special pathogen vaccines 1008
2 m& ?, E, r8 w- F' u42 Therapeutic cancer vaccines 1018
43 Cytomegalovirus vaccines 1032
- O2 p4 i/ v% ]. ^, K7 E" X44 Dengue vaccines 1042
1 y. j' k1 v0 |3 a  _1 e$ T! {& R45 Diarrhea caused by bacteria 1052
46 Ebola vaccine 1060
# M3 T; Z) o; _' v( i$ |47 Epstein-Barr virus vaccines 1068
8 i) n, R# ?' e) B! Q3 H# A48 Hepatitis C vaccines 1074
# G' X' d& t6 ]' s+ `! k* n7 w: P3 x49 Hepatitis E vaccines 1085
50 Herpes simplex virus vaccines 1090
51 Human immunodeficiency virus vaccines 1097
2 ?/ E6 ]. ^2 O- j6 h52 Lyme disease vaccines 1122
$ n8 Y+ g, F0 W53 Malaria vaccines 1133
, i% t" L0 l# W; H: T6 M54 Noninfectious disease vaccines 1138
" ?6 S$ l( l1 t0 u! N) v: ?1 Z! x, b55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
, @! C, B" ?  `0 k' C) a56 Parasitic disease vaccines 1154
- Y( f# N4 @0 O8 F57 Staphylococcus aureus vaccines 1161
( s3 i1 q; h) b- ?+ q+ K58 Streptococcus group A vaccines 1169
& N) P+ }9 Q* x+ r9 J# d59 Streptococcus group B vaccines 1176
- v  R: v, N, L# c60 Technologies for making new vaccines 1182
( J) u& |: L+ ~+ f9 b! W61 Alternative vaccine delivery methods 1200
62 The development of gene-based vectors for immunization 1232
/ S/ n5 s+ b1 ^, H7 b3 \SECTION 4: Vaccination of special groups
63 Vaccination of immunocompromised hosts 1243
64 Vaccination of human immunodeficiency virus-infected persons 1257
65 Vaccines for international travel 1270
. K* v, Z  W4 u66 Vaccines for health care personnel 1290
7 R7 f# x; e: k* tSECTION 5: Public health and regulatory issues
, ?$ ^/ t2 y1 A$ Q67 Immunization in the United States 1310
68 Immunization in Europe . 1334
: V  ]; h9 f1 ^8 [6 `( S. T69 Immunization in the Asia-Pacific region 1353
, d# B5 g( r- r  h  w70 Immunization in developing countries 1369
" V: a. n9 \4 T" B: _$ |71 Community immunity 1395
72 Economic analyses of vaccine policies 1413
9 k3 o7 M6 _* C& N" e/ G7 |: G, T2 v73 Regulation and testing of vaccines 1427
74 Regulation of vaccines in Europe 1447
1 T% p& V" ?: N& I4 m" R75 Regulation of vaccines in developing countries 1454
76 Vaccine safety 1464
77 Legal issues . 1481
78 Ethics 1508
# W0 ]- Q" M& b9 f- W  [& O

casarett

Vaccines, 6e, 2012
8 j' F- i) i8 N4 y- J( G
& a! M7 H. w# b4 d6 K+ CHardcover: 1570 pages
5 q& A; ~  g  E, x( `Publisher: Saunders; 6 edition (October 30, 2012)
3 r0 ~( `: }, l- N; OLanguage: English
( ?  N( ]7 n- BISBN-10: 1455700908
Size: 52.3mb (original pdf)
* g+ h' c" g2 q7 ]; M3 J6 {* Q" }
2013 BMA Medical Book Awards Highly Commended in Public Health!
$ {6 V  p& l# h# Q$ UApply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice!

Gain a complete understanding of each disease, including clinical characteristics, microbiology, pathogenesis, diagnosis, and treatment, as well as epidemiology and public health and regulatory issues.
  n5 b9 P7 k; M' f) O3 W* jUpdate your knowledge of both existing vaccines and vaccines currently in the research and development stage.
Get complete answers on each vaccine, including its stability, immunogenicity, efficacy, duration of immunity, adverse events, indications, contraindications, precautions, administration with other vaccines, and disease-control strategies.
' j$ c3 V9 e5 p, \4 eAnalyze the cost-benefit and cost-effectiveness of different vaccine options.
) A. ]3 I9 `" dClearly visualize concepts and objective data through an abundance of tables and figures.
9 G  x# W' q! k9 vPerform seamless searches of the complete text online, access all the references, and download all the images at www.expertconsult.com.
* H& P" e1 O9 {# k1 h' \Make optimal use of the latest vaccines for pneumococcal disease, rotavirus, human papillomavirus, herpes zoster, meningococcal disease, and much more.
8 a, a6 ]& z7 Q/ B- r, _Stay at the forefront of new developments with completely updated chapters on malaria and HIV vaccines, a new chapter on vaccine regulations across the world, and many other revisions throughout.

  \! y- @, Y* }: O5 J' Q  zDownload link: http://pan.baidu.com/s/1i5NxwLR
Code for downloading: dv96